HOME >> BIOLOGY >> NEWS
BioMed Central launches Biology Direct

BioMed Central is pleased to announce the launch of Biology Direct, a new online open access journal with a novel system of peer review. Biology Direct will operate completely open peer review, with named peer reviewers' reports published alongside each article. The journal also takes the innovative step of requiring that the author approach Biology Direct Editorial Board members directly to review the manuscript.

The journal, available online at www.biology-direct.com, launches with publications in the fields of Systems Biology, Computational Biology, and Evolutionary Biology, with an Immunology section to follow soon. Biology Direct considers original research articles, hypotheses, and reviews and will eventually cover the full spectrum of biology.

Biology Direct is led by Editors-in-Chief David J Lipman, Director of the National Center Biotechnology Information (NCBI) a division of the National Library of Medicine (NLM) at NIH, USA; Eugene V Koonin, Senior Investigator at NCBI; and Laura Landweber, Associate Professor at Princeton University, Princeton, NJ, USA. Lipman has long been interested in open access and has been central in the development of PubMed, GenBank and PubMed Central, the NLM's open access repository for literature in the life sciences.

Lipman and Koonin, speaking on the eve of the journal's launch, explain the motivation for establishing Biology Direct:

"We were compelled to launch this experiment because, while scientific publishing cannot be effective without peer review, we saw flaws in the current, predominantly, anonymous review system that run too deep to be rectified without a radical departure from the standard practices. It is our hope that the open peer-review system of Biology Direct, which allows a direct relationship between authors and reviewers, will be a major advantage for everyone involved - authors, readers, and reviewers alike."

Biology Di
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-207-631-9988
BioMed Central
5-Feb-2006


Page: 1 2 3

Related biology news :

1. BioMed Central announces new interdisciplinary Biofuels Journal
2. BioMed Central announces winners of first open access research awards
3. BioMed Central launches BMC Systems Biology, a new open access journal
4. Impressive new Impact Factors for BioMed Centrals open-access journals
5. BioMed Central applauds Wellcomes leadership on Open Access
6. BioMed Central welcomes the new National Institutes of Health public access policy
7. BioMed Central announces publishing partnership with The Scientist magazine
8. Woods Hole Research Center scientists study impacts of industrial logging in Central Africa
9. Central and peripheral signals set the circadian liver clock
10. Announcing the launch of Open Access Central
11. EMBL-EBI and collaborators win bid to run UK PubMed Central

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: BioMed Central launches Biology Direct

(Date:5/21/2013)... The American Chemical Society (ACS), the world,s largest ... 246th National Meeting & Exposition, September 8-12, 2013, ... the Indiana Convention Center and at area hotels. ... discoveries that span science,s horizons from astronomy ... broadcast and online journalists a rich assortment of ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
(Date:5/21/2013)... ANDOVER, Mass. , May 21, 2013 ... that CX50 xMATRIX, the world,s first portable ultrasound with ... Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available ... Paris at the EuroPCR, official ... (EAPCI), May 21-24. Since its launch in ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
(Date:5/21/2013)... 21, 2013  Personal Genome Diagnostics Inc. (PGDx), ... methodologies and expertise in genomic analysis of defined ... collaboration with Blueprint Medicines.  PGDx is an innovator ... alterations in tumors, and Blueprint Medicines is an ... a genetically defined patient population. "This ...
(Date:5/21/2013)... Minneapolis, MN (PRWEB) May 21, 2013 ... a patented automatic colony counter, announced today that they ... four products , the IncuCount, IntelliCount, InCount and ... price and sophistication are especially useful in food microbiology ... been given an updated look. A bright white ...
(Date:5/21/2013)... Mississauga, Ontario (PRWEB) May 21, 2013 ... expert scientists of the ITN to design the ... usefulness of two key clinical models used in ... Chamber (EEC) and Nasal Allergen Challenge (NAC) models. ... supported by numerous publications, to date no direct ...
Breaking Biology Technology:MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2
Cached News: